We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2784:TSEAlfresa Holdings Corporation Analysis

Data as of 2026-05-18 - not real-time

₩402,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

APR Co., Ltd. is trading above its short‑term and intermediate moving averages, reinforcing a bullish price momentum, while the Relative Strength Index sits near the neutral midpoint. Volume is on an upward trend, supporting the price advance, yet the MACD histogram remains negative, signaling a potential short‑term weakening of momentum. The stock’s 30‑day volatility is elevated, implying larger price swings, and the computed beta suggests limited sensitivity to broader market moves. Fundamentally, the company delivers exceptional gross and operating margins, robust cash generation, and a healthy dividend payout that appears sustainable given its cash reserves. However, a discounted cash‑flow valuation places the fair value well below the current market price, indicating the stock may be overvalued at present. Analyst consensus is strongly positive with a high target price, suggesting that market participants expect further upside despite the valuation gap. In summary, the blend of strong fundamentals and dividend appeal is tempered by technical signs of short‑term weakness and a valuation premium.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price above short‑term moving averages
  • negative MACD histogram indicating potential pullback
  • high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong revenue growth and high profit margins
  • analyst consensus of strong buy and elevated target price
  • sustainable dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • durable consumer defensive positioning
  • robust cash generation and low leverage relative to cash
  • consistent dividend policy enhancing shareholder value

Key Metrics & Analysis

Financial Health

Revenue Growth124.20%
Profit Margin18.96%
P/E Ratio21.3
ROE75.30%
ROA34.18%
Debt/Equity22.59
Op. Cash Flow₩341.0B
Free Cash Flow₩231.5B

Technical Analysis

TrendBullish
RSI48.9
Support₩388,000.00
Resistance₩473,000.00
MA 20₩426,000.00
MA 50₩376,650.00
MA 200₩272,956.50
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value₩223,985.57
Target Price₩479,615.38
Upside/Downside19.31%
GradeOvervalued
TypeBlend
Dividend Yield1.26%

Risk Assessment

Beta0.08
Volatility68.09%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.